GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of am I the only one who found hepatic fat harder than the injections — 14 comments in the full submission. View in context.
77
c/survodutide·submitted 2 months ago by u/lyophile_lou

am I the only one who found hepatic fat harder than the injections

Discussionbranch of 6 comments

Right, the glucagon question again, but with numbers this time. I have 7 data points over 8 weeks. The pattern is consistent enough that I do not think it is chance, and boring enough that nobody is going to screenshot it, which is usually a good sign. The thing I would flag for anyone new: the effect I am describing…

Read the full submission and all 14 comments →

This branch

6 comments, started 2 months ago
u/incretin_ivyMOD7 points·2 months ago

Retitled to remove editorialising. Put the evidence in the body.

replysharereportpermalink
u/peak_area_peteanalytical4 points·2 months ago

Australia here. Waited 3 months on a list, gave up, went private, and the total cost was roughly what I expected.

replysharereportpermalink
u/honest_syringe_pls3 points·2 months ago

Phase 24 or 40?

replysharereportpermalink
u/clara_restrepo8 points·2 months ago

Hepatic fat or MASH or what?

replysharereportpermalink
u/vitamin_d_void2 points·2 months ago

the safety profile is not just tirzepatide amplified

replysharereportpermalink
u/lyophile_louOP5 points·2 months ago

the UK here. Waited 19 months on a list, gave up, went private, and the total cost was roughly what I expected.

replysharereportpermalink

← back to the whole thread

About c/survodutide

Survodutide-specific discussion: glucagon-receptor co-agonism, the hepatic fat and MASH resolution data, and how the side-effect profile compares with GIP-based dual agonism. Small community, high signal.

12kmembers
62submissions
Feb 2024created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/survodutide rules
  1. Glucagon co-agonism has a distinct safety story. Do not generalise from tirzepatide.
  2. MASH claims need the trial and the biopsy endpoint.
  3. Not approved. Descriptive posts only.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.